Great work situation but company has changed significantly - Compliance Specialist Genentech Employee Review

4.0
May 27, 2026
Recommend
CEO approval
Business Outlook

Pros

Was a great situation, busy with work.

Cons

The past couple of years, lots of changes, downsizing, reorganization, even before I left, the company lost a lot of great, knowledgeable people. The company itself has changed a lot. I think it's more focused now on acquiring other smaller biotech/AI firms than on research, following the same business model, I guess, as other competitors. Sold their other site in Vacaville to a good CMO manufacturing company, I believe Lonza?

Explore other reviews about Genentech

5.0
Jun 1, 2026
Recommend
CEO approval
Business Outlook

Pros

Extremely experience team members and supportive corporate structure enables the field teams to execute on national strategy

Cons

The bonus structure can be a bit political

3.0
May 7, 2026
Recommend
CEO approval
Business Outlook

Pros

Genentech's origin story and mission are genuinely inspiring — few companies can point to such a meaningful historical arc in medicine. Patient engagement is taken seriously and feels authentic, not performative. The campus is beautiful and the culture has real warmth.

Cons

DDA is operating with significant gaps. First, the foundational data infrastructure is not mature enough to support the ambitions being set for the team. Second, the measurement culture has gotten ahead of the methodology, and no one in a position of authority seems to be asking hard questions about whether the numbers actually mean what they're being presented as meaning. Third, some management feel disconnected from the work itself, lacking the knowledge, hands-on experience, or relevant credentials. Individually any one of these would be manageable. Together these create an environment where it's hard to do rigorous work, rather work is performative, and be recognized for it.

1
See reviews by: Helpful|Rating|Date|All